The place of medical treatment of acromegaly in Serbia: current status

被引：1
作者：
Doknic, Mirjana [1 ,2 ]
Stojanovic, Marko [1 ,2 ]
机构：
[1] Univ Belgrade, Fac Med, Belgrade, Serbia
[2] Clin Ctr Serbia, Clin Endocrinol Diabet & Metab Dis, Dr Subotica 13, Belgrade 11000, Serbia
来源：
VOJNOSANITETSKI PREGLED | 2021年 / 78卷 / 10期
关键词：
acromegaly; combined modality therapy; dopamine agonists; drug therapy; pasireotide; pegvisomant; radiotherapy; somatostatin; treatment outcome; QUALITY-OF-LIFE; SOMATOSTATIN ANALOGS; PEGVISOMANT; COMBINATION; COMPLICATIONS; RADIOTHERAPY; CABERGOLINE; PREVALENCE; OCTREOTIDE; LANREOTIDE;
D O I：
10.2298/VSP200120036D
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1088 / 1095
页数：8
相关论文
共 59 条
  • [31] SAGIT®: clinician-reported outcome instrument for managing acromegaly in clinical practice-development and results from a pilot study
    Giustina, Andrea
    Bevan, John S.
    Bronstein, Marcello D.
    Casanueva, Felipe F.
    Chanson, Philippe
    Petersenn, Stephan
    Thanh, Xuan-Mai Truong
    Sert, Caroline
    Houchard, Aude
    Guillemin, Isabelle
    Melmed, Shlomo
    [J]. PITUITARY, 2016, 19 (01) : 39 - 49
  • [32] EXPERT CONSENSUS DOCUMENT A consensus on the medical treatment of acromegaly
    Giustina, Andrea
    Chanson, Philippe
    Kleinberg, David
    Bronstein, Marcello D.
    Clemmons, David R.
    Klibanski, Anne
    van der Lely, Aart J.
    Strasburger, Christian J.
    Lamberts, Steven W.
    Ho, Ken K. Y.
    Casanueva, Felipe F.
    Melmed, Shlomo
    [J]. NATURE REVIEWS ENDOCRINOLOGY, 2014, 10 (04) : 243 - 248
  • [33] Effective Combination Treatment with Cabergoline and Low-Dose Pegvisomant in Active Acromegaly: A Prospective Clinical Trial
    Higham, C. E.
    Atkinson, A. B.
    Aylwin, S.
    Bidlingmaier, M.
    Drake, W. M.
    Lewis, A.
    Martin, N. M.
    Moyes, V.
    Newell-Price, J.
    Trainer, P. J.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 97 (04) : 1187 - 1193
  • [34] The incidence and prevalence of acromegaly, a nationwide study from 1955 through 2013
    Hoskuldsdottir, Gudrun Thuridur
    Fjalldal, Sigridur Bara
    Sigurjonsdottir, Helga Agusta
    [J]. PITUITARY, 2015, 18 (06) : 803 - 807
  • [35] The place of medical treatment of acromegaly: current status and perspectives
    Jallad, Raquel S.
    Bronstein, Marcello D.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (08) : 1001 - 1015
  • [36] Optimizing Medical Therapy of Acromegaly: Beneficial Effects of Cabergoline in Patients Uncontrolled with Long-Acting Release Octreotide
    Jallad, Raquel S.
    Bronstein, Marcello D.
    [J]. NEUROENDOCRINOLOGY, 2009, 90 (01) : 82 - 92
  • [37] Personalized medicine in the treatment of acromegaly
    Kasuki, Leandro
    Wildemberg, Luiz Eduardo
    Gadelha, Monica R.
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2018, 178 (03) : R89 - R100
  • [38] Acromegaly: An Endocrine Society Clinical Practice Guideline
    Katznelson, Laurence
    Laws, Edward R., Jr.
    Melmed, Shlomo
    Molitch, Mark E.
    Murad, Mohammad Hassan
    Utz, Andrea
    Wass, John A. H.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2014, 99 (11) : 3933 - 3951
  • [39] The role of combination medical therapy in the treatment of acromegaly
    Lim, Dawn Shao Ting
    Fleseriu, Maria
    [J]. PITUITARY, 2017, 20 (01) : 136 - 148
  • [40] Current and future medical treatments for patients with acromegaly
    Maffezzoni, Filippo
    Formenti, Anna Maria
    Mazziotti, Gherardo
    Frara, Stefano
    Giustina, Andrea
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2016, 17 (12) : 1631 - 1642
123456